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A B S T R A C T
Background
Forty percent of individuals with early or intermediate stage cancer and 90% with advanced cancer have moderate to severe pain and up
to 70% of patients with cancer pain do not receive adequate pain relief. It has been claimed that acupuncture has a role in management
of cancer pain and guidelines exist for treatment of cancer pain with acupuncture.
Objectives
To evaluate efficacy of acupuncture for relief of cancer-related pain in adults.
Search methods
CENTRAL, MEDLINE, EMBASE, PsycINFO, AMED, and SPORTDiscus were searched up to November 2010 including non-
English language papers.
Selection criteria
Randomised controlled trials (RCTs) evaluating any type of invasive acupuncture for pain directly related to cancer in adults of 18
years or over.
Data collection and analysis
It was planned to pool data to provide an overall measure of effect and to calculate the number needed to treat to benefit, but this
was not possible due to heterogeneity. Two review authors (CP, OT) independently extracted data adding it to data extraction sheets.
Quality scores were given to studies. Data sheets were compared and discussed with a third review author (MJ) who acted as arbiter.
Data analysis was conducted by CP, OT and MJ.
Main results
Three RCTs (204 participants) were included. One high quality study investigated the effect of auricular acupuncture compared with
auricular acupuncture at ’placebo’ points and with non-invasive vaccaria ear seeds attached at ’placebo’ points. Participants in two
acupuncture groups were blinded but blinding wasn’t possible in the ear seeds group because seeds were attached using tape. This may
have biased results in favour of acupuncture groups. Participants in the real acupuncture group had lower pain scores at two month
follow-up than either the placebo or ear seeds group.
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There was high risk of bias in two studies because of low methodological quality. One study comparing acupuncture with medication
concluded that both methods were effective in controlling pain, although acupuncture was the most effective. The second study
compared acupuncture, point-injection and medication in participants with stomach cancer. Long-term pain relief was reported for
both acupuncture and point-injection compared with medication during the last 10 days of treatment. Although both studies have
positive results in favour of acupuncture they should be viewed with caution due to methodological limitations, small sample sizes,
poor reporting and inadequate analysis.
Authors’ conclusions
There is insufficient evidence to judge whether acupuncture is effective in treating cancer pain in adults.
P L A I N L A N G U A G E S U M M A R Y
Acupuncture for cancer-related pain in adults
Up to 70% of patients with cancer-related pain do not receive adequate pain relief and this reduces their quality of life. Acupuncture may
have a role to play in relieving cancer-related pain. This review evaluated evidence for the effectiveness of acupuncture in reducing pain
associated with cancer or its treatment, or both. We found three studies (looking at a total of 204 participants) which met our inclusion
criteria, but all had small sample sizes, leaving them prone to bias, and only one study was judged to be of high methodological quality.
The high quality study found that auricular (ear) acupuncture reduced cancer-related pain when compared with auricular acupuncture
at non acupuncture points, but the control group was not adequately blinded and this was likely to affect the outcomes. Of the low
quality studies, one found that acupuncture was as effective as medication, and one study found that acupuncture was more effective
than medication, but both studies were poorly designed and the study reports lacked detail. We concluded that there was insufficient
evidence to judge whether acupuncture is effective in relieving cancer-related pain in adults.
B A C K G R O U N D
Description of the condition
Cancer-related pain represents a major challenge in healthcare.
Forty percent of individuals with early or intermediate stage cancer
and 90% of individuals with advanced cancer have moderate to
severe pain (Laird 2008; Payne 1998). Pain in cancer patients may
be due to pre-existing pathologies, progression of the disease, tu-
mour growth, bone metastases (cancer-induced bone pain, CIBP)
or the treatment of cancer itself (Strong 2002; Twycross 2008;
Urch 2008). Bone pain due to metastatic cancer is often particu-
larly severe, unremitting and poorly controlled with patients often
having to take high doses of drugs with undesirable side-effects
(Gralow 2007). Up to 70% of patients with cancer-related pain
do not receive adequate pain relief and this affects physical and
psychological well-being, leading to a lower quality of life for the
patient (Keskinbora 2007; Vallerand 2007; van den Beuken-van
Everdingen 2007a; van den Beuken-van Everdingen 2007b).
Description of the intervention
Acupuncture is a treatment intervention delivered by practitioners
aligned to different philosophical paradigms (MacPherson 2007).
Acupuncture is used throughout the world to manage non-malig-
nant acute and chronic pain. It is claimed that acupuncture has a
role in the management of cancer pain (Alimi 2003; Dillon 1999;
Filshie 2004) and guidelines exist for the acupuncture treatment
of cancer pain (Filshie 2006). Anecdotal evidence suggests that it is
routinely used in clinical practice by physiotherapists for a variety
of pain states (Hopwood 2004) and increasingly by the medical
profession for pain relief in general (MacPherson 2007). Filshie
1990 described the use of acupuncture for malignant pain on 193
cancer patients over a five year period and reported that 56% of
patients had a ’worthwhile’ improvement for seven days or more
and 22% had an improvement for a ’limited duration’. A further
22% obtained no benefit at all.
There continues to be a debate about the efficacy of acupuncture
(Ernst 2006). Some systematic reviews and meta-analyses report
that acupuncture is superior to placebo or sham acupuncture for
osteoarthritis of the knee (Bjordal 2007; White 2007), peripheral
joint osteoarthritis (Kwon 2006), post-operative pain (Sun 2008),
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neck and shoulder pain (He 2004; Trinh 2006) and chronic low
back pain (Furlan 2005; Manheimer 2005). However, other re-
view authors have found limited efficacy for osteoarthritis of the
knee (Manheimer 2007), tension-type headache (Davis 2008) and
inconclusive evidence for shoulder pain (Green 2005) and chronic
pain in general (Ezzo 2000). A systematic review of systematic re-
views of acupuncture published between 1996 to 2005, claimed to
apply more rigorous inclusion criteria than previous reviews and
concluded that there was no robust evidence that acupuncture is
superior to a sham acupuncture control (Derry 2006). Trials com-
paring both acupuncture and sham acupuncture with patients on a
waiting list tended to show benefits of both acupuncture and sham
over the waiting list group. Sham acupuncture can either be a non-
penetrative sham (i.e. it has the appearance of real acupuncture
but the needle is blunt and does not penetrate the skin) or pene-
trative sham (i.e. where the needle penetrates the skin but is used
on non-acupuncture points). It has been suggested that the dosage
of acupuncture required for a beneficial effect is a minimum of six
treatments using at least four points at a frequency of at least once
a week, although the evidence supporting these recommendations
has not been widely researched (Ezzo 2000; White 2007). White
2007 also suggests that the needle sensation, ’de qi’, or in electro-
acupuncture a strong sensation of paraesthesiae must be achieved
for optimum benefit.
To date, there has only been one systematic review of acupunc-
ture for cancer pain (Lee 2005). This was not conducted using a
Cochrane protocol. Seven studies met the eligibility criteria: three
were RCTs and four were uncontrolled studies. Only one small
RCT was identified (Alimi 2003), and the investigators concluded
that auricular (ear) acupuncture provided statistically significant
pain relief when compared with placebo acupuncture. It was not
possible to meta-analyse the results of the review due to hetero-
geneity in pain states, patient populations and acupuncture proto-
cols in the identified studies. Four studies used body acupuncture,
two used auricular acupuncture and one used electro-acupuncture
(where an electric current is transmitted via the needles). Control
groups used were either patients receiving conventional therapies
or placebo/sham acupuncture. The review authors concluded that
there was insufficient good quality evidence to determine the ef-
fectiveness of acupuncture in relieving cancer pain. More recently,
Bardia et al (Bardia 2006) conducted a systematic review of the
effectiveness of complementary and alternative medicine therapies
for cancer related pain but was unable to evaluate the efficacy of
acupuncture because of insufficient good quality evidence.
Bone metastases are common in advanced cancers, particularly in
patients with multiple myeloma, breast, prostate or lung cancer
(Brainin-Mattos 2006; Lipton 2004). The incidence of bone in-
volvement has been said to exceed 90% in metastatic prostate and
breast cancers (Rosier 1998). Bone pain due to metastatic can-
cer is severe, unremitting and poorly controlled (Gralow 2007;
Ripamonti 2000). Mainstay treatments are opiates and bispho-
sphonates, although they can have severe adverse effects (Petrut
2008). Nowadays, the survival rate of many patients after diag-
nosis of bone metastases is relatively long; five year survival rates
have been quoted at 64% for metastatic breast disease and 46%
for metastatic prostate cancers (Coleman 2001). In view of this
it is important to control pain and preserve function to enable
these patients to enjoy as high a quality of life as possible (Qaseem
2008). Filshie 1990 claims that acupuncture is useful in ’selected’
patients with CIBP, where pain is difficult to control adequately
and pharmacological input is very high, resulting in unpleasant
side-effects. To date, no systematic reviews on acupuncture for
CIBP have been conducted and therefore the efficacy of acupunc-
ture as a treatment for CIBP is unknown.
Why it is important to do this review
To date, there have been no Cochrane reviews on acupuncture
for cancer-related pain. Clinical trials on acupuncture for cancer-
related pain have been published in recent years (Chen 2008;
Mao-Ying 2006; Mao-Ying 2008; Mehling 2007) so there is a
need to update the systematic review conducted by Lee et al (Lee
2005).
The high incidence of CIBP merits a subgroup analysis, although
preliminary searches have not revealed any controlled trials. It is
necessary to establish whether any studies exist, the quality of the
research and any important findings.
Within the review as a whole and in the subgroup analysis on
CIBP, studies with heterogeneous cancer populations will not be
excluded. However, heterogeneous studies will be identified and
discussed as part of the review.
O B J E C T I V E S
To evaluate the efficacy of acupuncture for the relief of cancer-
related pain in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) (crossover or parallel group
design) which evaluated any type of invasive acupuncture for can-
cer-related pain in adults were included, from inception of each
database onwards. These included studies which did not blind the
therapist because blinding an acupuncturist to the treatment is
problematical.
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Studies were excluded if they were non-randomised trials, case
reports, abstracts and letters (unless additional information from
published RCTs was included).
Types of participants
Male and/or female adult participants of 18 years or older were
included. They had cancer-related pain (as defined by commonly
used verbal rating scales or questionnaires), which was thought
to be directly linked to the development of their cancer and not
due to pre-existing pathologies or related to treatments; for ex-
ample, chemotherapy-induced neuropathic pain (Cata 2006); or
procedures such as surgery. We intended to review CIBP as our
subgroup analysis if the data allowed.
Types of interventions
Studies which evaluated any type of invasive acupuncture were in-
cluded. This included studies using manual acupuncture, electro-
acupuncture and auricular (ear) acupuncture. Both Western style
and traditional Chinese acupuncture were included.Western-style
acupuncture is characterised by its scientific approach, using a
physiologically-based rationale for the treatment and explanation
of its effects, whereas traditional Chinese acupuncture is based on
the ancient principles of Chinese medicine. Studies using differ-
ent forms of needle stimulation (such as electroacupuncture) and
different needling techniques were also included, but studies using
comparisons of non-invasive techniques such as laser acupuncture
or acupressure were excluded.
Pain outcomes may be compromised in studies which allow free
access to analgesic medication. It was planned to include such
studies in the review and analyse them as a sub-group for differ-
ences in analgesic consumption between groups.
It was also intended that a subgroup analysis would be carried
out on adequacy of acupuncture based on the following criteria
(White 2007):
• number of needles: ≥ 4 acupuncture points;
• needling technique: ≥ 20 minutes per session;
• needle sensation: reported as ’de qi’ or needle sensation for
manual acupuncture or a ‘strong sensation’ for
electroacupuncture;
• number of treatments: six treatments at least one per week.
The intervention to be compared with acupuncture would include
any of the following:
• no treatment;
• treatment as usual;
• non-penetrative sham (i.e. non-invasive treatment);
• penetrative sham (i.e. invasive treatment at non-
acupuncture points);
• other active interventions.
Types of outcome measures
Primary outcomes
The primary outcome measure was patient reported pain intensity
using validated scales (e.g. visual analogue scales (VAS), numerical
rating scales) or verbal reporting.
Secondary outcomes
Secondary outcome measures included any of the following:
• pain relief as measured by validated pain scales (e.g. VAS);
• patient satisfaction;
• quality of life;
• analgesic consumption and changes in concurrent
treatments;
• hospital attendance/admission (including Hospice
admission);
• adverse events (major or minor).
Search methods for identification of studies
Electronic searches
The following data sources were searched from the inception of
each database until October 2010:
1. the Cochrane Central Register of Controlled Trials
(CENTRAL);
2. MEDLINE;
3. EMBASE;
4. PsycINFO;
5. AMED;
6. SPORTDiscus.
Detailed search strategies were developed for each electronic
database searched in order to identify studies suitable for inclusion
in the review. These were based on the search strategy developed
for MEDLINE, but were revised according to the database being
used (see Appendix 1; Appendix 3; Appendix 4; Appendix 5; and
Appendix 6).
The MEDLINE search was carried out with the following filter:
Cochrane Highly Sensitive Search Strategy (CHSSS) for identi-
fying randomised trials in MEDLINE via Ovid, as published in
Chapter 6.4.11.1 of the Cochrane Handbook for Systematic Re-
views of Interventions, version 5.0.1 (Higgins 2008).
The search strategy attempted to identify all relevant studies ir-
respective of language. Non-English papers were assessed for rel-
evance and decisions on translation were taken on a case-by-case
basis, as suggested in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2008).
4Acupuncture for cancer pain in adults (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Searching other resources
Reference lists of eligible studies and previous systematic reviews
were also reviewed to identify further eligible studies.
Data collection and analysis
The study selection process is shown in Figure 1.
Selection of studies
Two review authors (CP and OT) with a third review author (MJ)
acting as arbiter independently selected the studies to be consid-
ered in the review following the literature searches described in the
previous section.
Data extraction and management
Data extractionwas conducted up to and includingOctober 2010.
A search log was completed, showing databases searched and the
dates of searches. A data extraction sheet was completed for ev-
ery study included in the review. Information recorded included
details of authors, participants, study design, characteristics of in-
tervention (acupuncture style, type of needle, number of needles,
needling technique, needle sensation and number of treatments)
and comparator, any adverse effects and baseline/end of study out-
comes.
Assessment of risk of bias in included studies
A modified version of the validated Oxford five-point Quality
Scale (Jadad 1996;White 1999) was used to assess quality because
the original Jadad scale incorporates blinding of the acupunctur-
ist, which is virtually impossible. Two review authors completed
the data extraction and scored each study (CP and OT) with a
third review author (MJ) acting as arbiter where differences oc-
curred between the two review authors. The scores were used to
assess overall quality. Themaximum score was five. Studies scoring
three or more points were considered as high quality. The points
achieved for each of the studies were listed in a table and were used
in the assessment of risk of bias Table 1.
Methodological quality was independently assessed using the
Cochrane Collaboration’s tool for assessing risk of bias in RCTs
(Higgins 2008). Risk of bias was summarised and differences in
author interpretation of data was settled through discussion.
Measures of treatment effect
It was planned that data from the outcomes of each study would be
pooled to provide an overall measure of the effect of acupuncture
on cancer-related pain, except where different cut-off points were
used (see below). For continuous data, it was intended that results
would be presented as weighted mean differences (WMD). How-
ever, if different pain scales were used in the acupuncture studies it
was planned that this data would be presented using standardised
mean differences (SMD) where appropriate. Where dichotomous
data existed, relative risk (RR) would be used.
Unit of analysis issues
The problem of dividing categorical data into dichotomous out-
comes provides a potential source of bias as study authorsmight use
different cut-off points for the data in each group. It was planned
that outcomes from data with different cut-off points or data from
clinically heterogeneous studies would not be pooled as described
above. Data would be combined for all treatment periods.
Dealing with missing data
It was planned that studies with missing data would be described
in the text and illustrated using tables as appropriate. To avoid
bias arising frommissing data, an intention-to-treat analysis (ITT)
would be performed where data was continuous, using the last
observation on each participant carried forward until the study
endpoint. Where missing dichotomous data was identified it was
planned that these would be assigned positive and negative out-
comes in equal proportions. If the number of missing values was
significant it was decided that it might be necessary to perform
a sensitivity analysis to estimate the effect of the ITT analysis on
the overall outcome. It was planned that this would be carried out
by assuming a positive outcome for all missing data, followed by
a negative outcome for the missing data and then assuming that
the outcome would lie near the midpoint between the two values.
It was decided that studies with a high attrition rate (50% or more)
would not be excluded from the review because it was expected
that there would be very few studies meeting the inclusion criteria.
Assessment of heterogeneity
It was planned that a Chi squared test would be used to estimate
heterogeneity of both the SMD and relative risk (RR). Further
analysis could be performed using the I2 test. If possible, a forest
plot would also be constructed for analysis. Where heterogeneity
was statistically significant, it was planned that a random-effects
model would be used to interpret the results. If heterogeneity was
not statistically significant, a fixed-effect model would be used.
Potential sources of heterogeneity exist in the outcomes used (e.g.
differences in methods of reporting pain), population (differences
in cancer site and nature, or cause of pain, age, gender, etc.), com-
parators used (e.g. sham/placebo, waiting list) and study design.
It was planned that all studies identified for the review would be
analysed to identify possible sources of heterogeneity and discussed
in the text of the review.
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Assessment of reporting biases
If the review authors did not find a large number of studies it was
decided that publication or inclusion bias would not be assessed.
However, if enough studies were available and a meaningful as-
sessment of publication bias could be carried out, it was planned
that a funnel plot would be constructed.
Data synthesis
If the data could be combined into a meta-analysis, categorical
data would only be included where it could be divided into di-
chotomous outcomes. If the data could not be combined in a
meta-analysis it was decided that this would be summarised in the
text and grouped by outcome as appropriate. All data would be
entered using RevMan 5 analysis software.
Subgroup analysis and investigation of heterogeneity
Where the data allowed, we planned to separate the outcome anal-
yses and perform a subgroup analysis on outcomes of studies using
acupuncture specifically for CIBP.
Sensitivity analysis
It was planned that other sources of heterogeneity would be ex-
plored using sensitivity analysis to determine the effects of the
method of acupuncture treatment, overall methodological quality
and use of ITT analysis. If there were any studies with high at-
trition rates (over 50%) they were to be removed from the meta-
analysis to determine whether the results would be significantly
different without them.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
See the ’Characteristics of included studies’ and ’Characteristics
of excluded studies’ tables.
Results of the search
For inclusion in the review, studies had to meet all of the three
main eligibility criteria which were:
• Investigations of acupuncture for cancer pain;
• Studies containing clinical data;
• Randomised controlled trials (RCTs).
Case reports, abstracts and letters were excluded. Where abstracts
for RCTs were identified the full reports were sought and included
if available. A flowchart showing the selection process is shown in
Figure 1. In total, 253 references were identified from the literature
search of which it was possible to exclude 226 from the title alone
as not meeting our eligibility criteria. Abstracts were obtained for
the remaining 27 studies and a further 10 were excluded because
they were not acupuncture studies, were not studies on cancer
pain or they were either systematic reviews or not RCTs. Three
studies could not be excluded at this stage because they required
translating from French (Nguyen 2005), German (Meng 2002)
andChinese (Chen 2008). Full study reports were obtained for the
remaining 17 studies and a further 13 were subsequently excluded
because further examination revealed that theywere post-operative
studies, did not have pain as amain outcomemeasure or translation
revealed that they did not meet the eligibility criteria of being a
RCT. Three studies were included in the final review (Alimi 2003;
Chen 2008; Dang 1998) and one study (Dang 1997) was added
as a secondary reference to Dang 1998.
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Figure 1. Systematic Review Process Flowchart
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Included studies
Three studies (looking at a total of 204 participants) met our
criteria for inclusion, please see the ’Characteristics of included
studies’ table. An additional study was identified (Dang 1997)
but because it contained data duplicated in a later report it was
included as a secondary reference for an included study (Dang
1998).
Alimi 2003 randomly assigned 90 participants with chronic pe-
ripheral or central neuropathic pain related to cancer to to one of
the three groups:
• Auricular acupuncture using semi-permanent needles;
• Auricular acupuncture using semi-permanent needles
administered at non-acupuncture (placebo) points;
• Non-invasive auricular ’seeds’ administered at non-
acupuncture (placebo) points.
Mean pain intensity on visual analogue scale (VAS) was similar in
each group at baseline (57 to 58 mm). Each group received two
courses of treatment with needles or seeds left in situ and were
asked not to modify their analgesic medication during the course
of the study.The duration of each course was determined by the
time it took the needles to fall out or for the ear seeds to become
unstuck and fall off. Pain scores were recorded at 1 month (termed
D30 in the report) and 2 months (termed D60 in the report).
Measures of electrodermal response at points on the ear were also
taken at the same intervals. No adverse events were reported by
either participants or their doctors. The main outcome measure
was pain at 2 months, with secondary outcomes being pain at 1
month and electrodermal response at 1 and 2 months.
The reported results showed a significant decrease in pain intensity
of 36% (58 mm to 37 mm on VAS) from baseline at 2 months in
the acupuncture group with an insignificant change in the group
having acupuncture at placebo points (58 mm to 55mm on VAS).
The differences between the acupuncture and placebo acupunc-
ture groups was statistically significant (P < 0.0001). Pain scores
at 1 month were also lower in the true acupuncture group than
either of the other two groups.
Chen 2008 conducted a parallel group study comparing acupunc-
ture to analgesic medication. This paper was written in Chinese
and was translated by colleagues within our University Depart-
ment to obtain a description of the methodology and results. Sixty
six adult participants (age range of 41 to 70 years) with pain as-
sociated with “late” but unspecified cancer were categorised into
groups according to pain severity - “mild”, “moderate” and “se-
vere”. Participants received either acupuncture applied at 3 to 5
’tender’ acupuncture points, or analgesic medication based on the
WorldHealthOrganisation (WHO)3-step principle and included
aspirin for mild pain, codeine for moderate pain and morphine
for severe pain. No placebo control group was included.
Pain intensity was measured by change in visual analogue score.
Participants were categorised into groups according to the change
in pain intensity relative to baseline as follows:
• Complete Relief = visual analogue score (VAS) changes of
91 to 100% reduction in pain intensity from baseline.
• Average relief = VAS changes of 61 to 90% reduction in
pain intensity from baseline.
• Partial relief = VAS changes of 31 to 60% reduction in pain
intensity from baseline.
• No relief = VAS changes of less than 31% reduction in pain
intensity from baseline.
The percentage of participants in each category falling into each
of the above category was calculated and recorded and a cut-off
point of pain relief of 31% or more set as criteria for “general effec-
tiveness”. It was concluded that the analgesic effect of acupuncture
was significantly more effective than medication with the total ef-
fectiveness of acupuncture reported as 94% in the acupuncture
group and 87.5% in the medication group (P < 0.05).
It was not possible to extract data because no raw data or standard
deviations were reported.
Dang 1998 randomly allocated 48 participants with pain from
stomach carcinoma to receive one of three treatments:
• Acupuncture (filiform needle) n = 16;
• Acupuncture point injection with human transfer factor n =
16;
• Western medicine (analgesic medication based on the
WHO analgesic ladder) n = 16.
In addition a group of 16 healthy normal participants were as
used as a control. This group did not receive any treatment and
it was assumed that the control group was included for compari-
son of biochemical data over the course of the study (e.g. leuko-
cyte count). Acupuncture was administered at 4 to 5 ’main points’
and 2 to 4 ’auxiliary points’ according to traditional acupuncture
points and based on the patient’s signs and symptoms. Needles re-
mained in situ for 20 minutes. Treatment was given continuously
for 2 weeks followed by a gap of 2 to 3 days before continuing.
The total treatment period was 2months. Each acupuncture treat-
ment course consisted of one treatment per day for grade I pain
and 2 to 3 sessions per day for grade II or III pain (according to
the WHO criteria). For the point injection group an injection of
0.5 ml of freeze-dried human transfer factor aqueous solution was
administered into four acupuncture points selected in a similar
manner to the acupuncture group. This was done twice per week.
Participants in theWestern medicine group received analgesics in-
cluding aspirin, indomethacin, AP-237, codeine, dihydrocodeine
and dolantin, based on the WHO 3-step ladder. Transient effects
(30 minutes after treatment) and long-term effects (12 hours post-
treatment) were calculated for the first 10 days of treatment and
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the final 10 days of treatment over a 2 month period. At each stage
of the study participants were categorised into groups according
to the effectiveness of treatment: ’Markedly Effective’, ’Improved’
and ’Ineffective’. The percentage of participants in the ’Markedly
Effective’ and ’Improved’ categories groups were used as a mea-
sure of effectiveness. No explanation was given as to how pain was
measured and how participants were categorised into these groups
even after referring to the earlier paper, Dang 1997, for further
details.
The results indicated that medication provided more effective
analgesia during the first 10 days of treatment when considering
both transient and long-term effects. During the final 10 days of
treatment the transient effects of the acupuncture and point in-
jection group were similar to the medication group and the long-
term effects were equal (P > 0.05). However, taking only the long-
term ’markedly effective’ scores for the acupuncture (48.8%) and
point injection (51.9%) groups during the final 10 days of treat-
ment, these were significantly higher than in themedication group
(33.8%) (both P < 0.05).
A summary of the three included studies can be found in Table 2.
Excluded studies
Most of the papers identified through our searches as being on
acupuncture for cancer pain did not contain clinical data. After the
initial screening by title and abstract, 17 studies remained and 13
of these were subsequently excluded. Two studies were excluded
because they were not randomised (Aung 1994; Guo 1995). Two
of the three studies that were not written in English were initially
included (Meng 2002; Nguyen 2005) because a translation was
not available at the initial screening. Translated abstracts were ob-
tained at a later date which enabled us to exclude these studies
as neither were clinical trials. Xia 1986 was excluded after dis-
cussion because pain was not a primary outcome measure and
some of the participants were suffering from post-operative pain
which excluded the study from the review. Poulain 1985 was also
a study of postoperative pain and was excluded on this basis. The
studies by Carr 2002 and Goudas 2001 were narrative reviews of
the evidence and Yu 1992 was a discussion paper. Minton 2007
was a letter, although this wasn’t clear in the initial screening by
title and abstract. The study by Zhang 2006 fitted many of the
inclusion criteria but was a study of herbal medicine for cancer
pain with no acupuncture. A search conducted just prior to pub-
lication identified two further studies that were potentially eligi-
ble (Akhileswaran 2010; Sima 2009). Both of these studies were
only available as conference abstracts with no traceable published
papers and therefore did not meet our inclusion criteria. Con-
tact details for the authors were not provided in either of the ab-
stracts. Nevertheless, the work conducted by Sima 2009 is worthy
of mention because it provides some clinical data from an RCT in-
vestigating the effects of electroacupuncture on neuropathic pain
and other measures in patients with metastatic breast and lung
cancer. The study found that acupuncture alleviated neuropathic
bone pain and decreased consumption of analgesics as compared
with a control group receiving acupuncture on non-acupuncture
points. However, insufficient information was available within the
abstract on the control group intervention.
Risk of bias in included studies
A modified version of the five-point Oxford Quality Scale (Jadad
1996; White 1999) was used to assess methodological quality
(Table 1). One study scored four out of five points and met the
criteria for a high quality study (Alimi 2003). This study lost one
point for subject blinding because although the acupuncture and
placebo acupuncture groups were blinded, participants receiving
ear seeds were not blinded as the seeds had to be fixed with ad-
hesive tape. The two remaining studies (Chen 2008; Dang 1998)
both received two points out of five. They both lost one point for
not reporting participant blinding, one point for not reporting
assessor/evaluator blinding and one point for not reporting partic-
ipant withdrawals/dropouts.These studies were therefore deemed
to be of low methodological quality. Risk of bias was also assessed
and this information is summarised in the Risk of bias in included
studies and Figure 2. It is clear from this information that although
Alimi 2003 received the highest score for methodological quality
according to the five-point scale, additional risk of bias’ was intro-
duced by the wide variation in the number of days the needles or
ear seeds remained affixed to the ear and also in the fact that some
of the participants changed their analgesic medication, which was
contrary to the study protocol.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
Effects of interventions
Alimi 2003, found a significant decrease in pain intensity recorded
on VAS at 1 month and 2 months. Participants in the true
acupuncture group had significantly lower pain scores at 2months
than either the placebo acupuncture or ear seeds group (P < 0.001)
with an overall 36% decrease in pain intensity as measured on a
VAS. There was little change in pain intensity recorded for the
placebo acupuncture group (2%).
Chen 2008, reported that acupuncture wasmore effective (94.1%)
as compared with medication (87.5%) (P < 0.05). The percentage
of participants showing an improvement in VAS scores of 31%
or more was used as a measure of ’general effectiveness’ and the
difference was tested again using chi squared. These results should
be treated with caution as the description and reporting of the
study is unclear and the method of analysis debatable.
Dang 1998 reported that the western medication group experi-
enced more effective immediate analgesia during the first 10 days
than the filiform needle or point injection groups, but by the final
10 days the effects were similar. There were no significant differ-
ences between the groups in either transient or long-term effects.
The use of ordinal categories for pain relief without specifying pa-
rameters make additional comparisons of trial data meaningless.
Also, the pain outcomes in this study were linked to improving
sleep and other quality of life criteria which presents a confusing
picture.
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D I S C U S S I O N
Summary of main results
This review illustrates how few studies of acupuncture for cancer
pain exist. We found no additional high-quality evidence since
the last systematic review of acupuncture for cancer pain by Lee
2005. There remains only one high-quality study (Alimi 2003)
which shows positive results for auricular (ear) acupuncture over
placebo. A low-quality study on participants with stomach carci-
noma (Dang 1998) failed to show a significant difference between
conventional analgesia and acupuncture within the first 10 days
of treatment, but indicated an increased long-term analgesic ef-
fect over western medicine during the final 10 days. Inadequacy
of outcome measures, absence of reliable statistical methodology
and failure to report blinding undermines this evidence. A low
quality study reported significant benefits of acupuncture over
conventional medication (Chen 2008) although the method of
analysis was poor and raw data was not available. The study was
poorly reported with no mention of blinding. The heterogeneity
of methodologies, cancer populations and techniques used in the
included studies precluded pooling of data and therefore meta-
analysis was not carried out. A subgroup analysis on acupuncture
for CIBP was not conducted because none of the studies made
any reference to bone pain.
When adequacy of acupuncture dose was examined the high-qual-
ity auricular study (Alimi 2003) reported the use of an average of
six auricular points and an average treatment durationwas 44min-
utes. This partially meets the criteria for adequacy as suggested by
White 2007, but it was unclear howmany treatments were carried
out and needle sensation was not reported. One low quality study
used less than six needles and did not report the frequency of treat-
ment sessions (Chen 2008). The other low quality study reported
adequate duration, frequency and points used but the frequency
of treatment varied depending on the level of pain reported (Dang
1998). Reference was made to achieving ’de qi’ (needle sensation)
in just one of the studies (Dang 1998) which mentioned the need
to concentrate the mind on the diseased site to promote needle
sensation.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from one high-quality RCT is insufficient to provide
a judgement onwhether acupuncture is effective in treating cancer-
related pain in adults, although acupuncture is used quite widely
for this purpose and for other cancer-related conditions. As peer-
reviewed guidelines exist for the use of acupuncture in cancer
patients (Filshie 2006) it is suggested that practitioners follow
these guidelines and that patients are made aware of the potential
limitations of this type of intervention.
Implications for research
Acupuncture is widely used to treat cancer-related pain, but the
available evidence is inconclusive or of low quality. Therefore a
judgement on whether acupuncture is effective cannot be made
and more large RCTs are required with particular attention given
to:
• power calculations to ensure adequate sample sizes;
• homogeneity of cancer pain conditions under study;
• use of optimal dose of acupuncture;
• assessor blinding;
• use of valid and reliable pain outcome measures;
• the nature of the control used.
Trials of acupuncture comparing with sham and placebo interven-
tions which control for patients’ expectations and beliefs about the
effects of treatment have beenused todeterminewhether acupunc-
ture has specific effects over and above a placebo response (Ernst
2004; Ernst 2006; Johnson 2006). However, findings have been
inconsistent and there is an ongoing debate as to whether sham
and placebo acupuncture is appropriate as a control because it may
not be physiologically inert and as powerful as verum (acupunc-
ture) (Lund 2009; Lundeberg 2008). Therefore pragmatic trials
of the effectiveness of acupuncture on cancer pain compared with
standard treatment may provide useful information (Lundeberg
2009) but attention should be given to ensuring an adequate dose
of acupuncture is given in line with current recommendations
(White 2008).
As no studies investigating acupuncture for CIBP were identified,
this is an area which should be specifically targeted for further
research.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Alimi 2003
Methods RCT, 3 arms
Participants 90 adult participants with cancer pain ≥ 30 mm on VAS for at least 1 month. Excluded
if had acupuncture before. Age range 37-84. All patients were on stable analgesia
Interventions 2 treatments of auricular acupuncture at points selected according to electrodermal
response (n=29)
Auricular acupuncture at placebo points (n=30)
Auricular seeds at placebo points (n=31)
Outcomes Pain on VAS
Pain after 1 month and 2 months
Average electrical potential differences at 1 and 2 months
Notes Analgesic medication recorded in self-report diary
Modified Oxford quality score: 4
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Blinded computer-generated randomisation was used
Allocation concealment (selection bias) Low risk Allocation concealment was maintained for both acupuncture
groups but not for the ear seeds group as these were easily iden-
tifiable by their adhesive strips
Blinding (performance bias and detection
bias)
All outcomes
High risk Acupuncture and placebo acupuncture subjects blinded
Ear seeds group not blinded
The acupuncturist was not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Withdrawals and missing data adequately described. These in-
cluded 5 refusals of second course of treatment and 3 changes
of analgesia before the second course of treatment
Other bias High risk Wide variation in number of days needles or ear seeds remained
attached to the ear. Ranges from 2-25 days for acupuncture, 3-
33 days for placebo acupuncture and 1-34 days for ear seeds
Some patients altered their analgesic intake during the course of
the study but their results were included in the final report
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Chen 2008
Methods RCT, 3 arms
Participants 66 participants with cancer pain randomised to 3 groups: mild pain, moderate pain and
severe pain
Each of 3 pain groups randomly divided into an acupuncture group and an oral medi-
cation group
Interventions Acupuncture group andoralmedication group according toWHO3step administration:
Mild pain - aspirin
Moderate pain - codeine
Severe pain - morphine
Outcomes Pain scores measured on a VAS, with response percentage calculated as [(score before-
score after)/score before] x 100
Analgesic effect reported from percentage difference in pain score. Complete relief (CR)
91-100%, average relief (AR) 61-90%, partial relief (PR) 31-60%, or no relief (NR) less
than 31%
Notes Translated from Chinese
Modified Oxford quality score: 2
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation tables used to allocate subjects to the acupunc-
ture or medication groups. It was not clear whether randomisa-
tion was carried out by blinded personnel
Allocation concealment (selection bias) Unclear risk Allocation concealment was not clearly stated
Blinding (performance bias and detection
bias)
All outcomes
High risk Participant and evaluator blinding not described
Incomplete outcome data (attrition bias)
All outcomes
High risk Incomplete data and withdrawals not described
Other bias High risk Poor reporting of intervention and methodology
Inadequate statistical analysis
Dang 1998
Methods RCT using a block design with 3 pain groups, 2 intervention arms and 2 control groups
Participants 48 gastric cancer participants divided into 3 groups: mild, moderate and severe pain.
Males and females aged 37-75. 16 normal controls were also included
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Dang 1998 (Continued)
Interventions Filiform needle group (n=16): 7 main points (4-5 each session + 2-4 adjuvant points),
20 mins. Grade I patients treated daily, grades 2 & 3 treated 2-3 times daily. Each course
2 weeks with 2-3 days in between courses over a 2 month period
Point injection group (n=16): 4 main points x 2 per week over 2 months. Injected with
transfer factor
Western Medicine group (n=16): analgesia was administered according to the WHO
guidelines
Normal controls (n=16): no intervention
Outcomes Pain during the first 10 days and the final 10 days based on the Graded WHO criteria
Changes in Leucine-enkephalin in plasma (PLEK)
Changes in CuZn-superoxide (CuZn-SOD) dismutase activity in whole blood
Patient-reported chemotherapy reactive symptoms (e.g. dizziness, vomiting)
Notes Modified Oxford quality score: 2
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised block experimental design
used but method of randomisation not de-
scribed, nor whether this was carried out
by blinded personnel
Allocation concealment (selection bias) High risk Allocation concealment was not stated
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding described
Incomplete outcome data (attrition bias)
All outcomes
High risk Incomplete data and withdrawals not de-
scribed
Other bias High risk Inappropriate control group of normal
healthy participants
Poor reporting of methodology and inter-
vention
RCT = Randomised, controlled trial
VAS = Visual analogue score
WHO = World Health Organisation
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Akhileswaran 2010 Conference abstract with no traceable published paper
Aung 1994 Not a RCT of acupuncture for cancer pain
Carr 2002 Narrative review of evidence on acupuncture for cancer pain. No clinical data included
Goudas 2001 Narrative review of evidence on acupuncture for cancer pain. No clinical data included
Guo 1995 This contained clinical data on acupuncture for cancer pain but was not a RCT
Meng 2002 This is a discussion paper on the use of traditional Chinese medicine in oncology
Minton 2007 This is a letter within a journal and contained no clinical data
Nguyen 2005 This is a systematic review of acupuncture for cancer pain
Poulain 1985 This study investigated pre and post-operative analgesia in cancer patients compared with acupuncture analgesia
Sima 2009 Conference abstract only. No traceable published paper
Xia 1986 Pain was not a main outcome measure in this study
Yu 1992 This is a discussion paper on the use of traditional Chinese medicine to control cancer pain, and includes
various traditional Chinese interventions. No clinical data is included
Zhang 2006 This was a study on the use of herbal treatments for cancer pain. No acupuncture was included
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D A T A A N D A N A L Y S E S
Comparison 1. Alimi 2003 - Auricular acupuncture vs placebo
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on VAS at 2 months 1 57 Std. Mean Difference (IV, Random, 95% CI) -0.82 [-1.36, -0.28]
Comparison 2. Alimi 2003 - Acupuncture vs placebo ear seeds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on VAS at 2 months 1 59 Std. Mean Difference (IV, Random, 95% CI) -1.06 [-1.61, -0.51]
Comparison 3. Alimi 2003 - Placebo acupuncture vs placebo ear seeds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on VAS at 2 months 1 58 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.65, 0.38]
Analysis 1.1. Comparison 1 Alimi 2003 - Auricular acupuncture vs placebo, Outcome 1 Pain on VAS at 2
months.
Review: Acupuncture for cancer pain in adults
Comparison: 1 Alimi 2003 - Auricular acupuncture vs placebo
Outcome: 1 Pain on VAS at 2 months
Study or subgroup Acupuncture Placebo acupuncture
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Alimi 2003 29 37 (19) 28 55 (24) 100.0 % -0.82 [ -1.36, -0.28 ]
Total (95% CI) 29 28 100.0 % -0.82 [ -1.36, -0.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.97 (P = 0.0030)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours experimental Favours control
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Analysis 2.1. Comparison 2 Alimi 2003 - Acupuncture vs placebo ear seeds, Outcome 1 Pain on VAS at 2
months.
Review: Acupuncture for cancer pain in adults
Comparison: 2 Alimi 2003 - Acupuncture vs placebo ear seeds
Outcome: 1 Pain on VAS at 2 months
Study or subgroup Acupuncture Placebo ear seeds
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Alimi 2003 29 37 (19) 30 58 (20) 100.0 % -1.06 [ -1.61, -0.51 ]
Total (95% CI) 29 30 100.0 % -1.06 [ -1.61, -0.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.80 (P = 0.00014)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours experimental Favours control
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Analysis 3.1. Comparison 3 Alimi 2003 - Placebo acupuncture vs placebo ear seeds, Outcome 1 Pain on
VAS at 2 months.
Review: Acupuncture for cancer pain in adults
Comparison: 3 Alimi 2003 - Placebo acupuncture vs placebo ear seeds
Outcome: 1 Pain on VAS at 2 months
Study or subgroup Placebo acupuncture Placebo ear seeds
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Alimi 2003 28 55 (24) 30 58 (20) 100.0 % -0.13 [ -0.65, 0.38 ]
Total (95% CI) 28 30 100.0 % -0.13 [ -0.65, 0.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.51 (P = 0.61)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours experimental Favours control
A D D I T I O N A L T A B L E S
Table 1. Modified Oxford 5-Point Quality Scale for Assessment of Methodological Quality
Criteria Alimi 2003 Chen 2008 Dang 1998
Study described as randomised
(+1)
1 1 1
Appropriate randomisation
method used (+1)
1 1 1
Inappropriate method of ran-
domisation (-1)
- - -
Subject blinded (+1) 0 0 0
Evaluator blinded (+1) 1 0 0
Dropouts/withdrawals
described
1 0 0
SCORE 4 2 2
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Table 2. Acupuncture for cancer pain in adults: Summary of included studies
Author (year) Design Method quality
score
Groups and in-
terventions
Pain outcome
measures
Secondary out-
comes
Pain results
Alimi 2003 RCT, n=
90 single-blind 3
groups
4 Auric-
ular acupuncture
(n=29)
Auric-
ular acupuncture
at placebo points
(n=30)
Auricular seed
at placebo points
(n=31)
Pain intensity on
VAS at D30 and
D60
Average electrical
potential differ-
ence at D30 and
D60
Pain intensity on
VAS significantly
decreased in
acupuncture
group compared
with placebo at
both D30 and
D60
Chen 2008 RCT n=66
3 groups, 2 sub-
groups for each
group
2 3 groups: mild,
moderate and se-
vere
pain, each group
randomly subdi-
vided into 2 sub-
groups: acupunc-
ture
group and medi-
cation group
Analgesic effect:
Complete relief
(CR)
Average relief
(AR)
Partial Relief
(PR)
No relief (NR)
None reported Gen-
eral effectiveness
(%) in Acupunc-
ture group: Mild
pain=100%;
Mod pain=94.
4%; severe pain=
91.7%
In Medica-
tion group: Mild
pain=75%; Mod
pain=89.5%; Se-
vere pain=88.9%
Groups com-
pared for gen-
eral effectiveness:
Acupuncture=
94.1% Medica-
tion=87.5%
Dang 1998 RCT, n=48, 4
groups
2 3 pain
groups randomly
divided into: Flil-
form Nee-
dle, Point Injec-
tion and Western
Medicine (medi-
cation) groups. 1
control group of
normal subjects
Treatment effec-
tiveness % score
based on 3 cate-
gories:
Markedly effec-
tive
Improved
Ineffective
Categories
include pain,
vigour, sleep and
appetite.
PLEK concentra-
tion
Quality of life
Chemotherapeu-
tic reaction
E-RFR (%)
Leukocyte count
Af-
ter 2 months to-
tal effective rates
of analgesia were
around 81% for
FN, PI and WM
groups and the
markedly effec-
tive scores were
FN 48.8%, PI
51.9% and WM
33.8%
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp Acupuncture Therapy/ (11796)
2. exp Medicine, East Asian Traditional/ (9312)
3. Acupuncture/ (860)
4. (acupuncture or acupressure or acupoint* or electroacupuncture or electro-acupuncture or meridian* or moxibust* or
“traditional chinese medicine” or “traditional oriental medicine”).mp. [mp=title, original title, abstract, name of substance word,
subject heading word] (19418)
5. 4 or 1 or 3 or 2 (26132)
6. exp Neoplasms/ (2075388)
7. (neoplasm* or cancer* or carcino* or malignan* or tumor* or tumour*).mp. [mp=title, original title, abstract, name of substance
word, subject heading word] (2221292)
8. or/6-7 (2483290)
9. exp Pain/ (246185)
10. pain*.mp. [mp=title, original title, abstract, name of substance word, subject heading word] (376859)
11. Analgesia/ (11230)
12. (analges* or nocicept* or neuropath*).mp. [mp=title, original title, abstract, name of substance word, subject heading word]
(189913)
13. or/9-12 (559785)
14. 13 and 8 and 5 (275)
15. randomized controlled trial.pt. (280165)
16. controlled clinical trial.pt. (80498)
17. randomized.ab. (189021)
18. placebo.ab. (115356)
19. drug therapy.fs. (1346163)
20. randomly.ab. (136940)
21. trial.ab. (195831)
22. groups.ab. (935356)
23. or/15-22 (2465926)
24. exp animals/ not humans.sh. (3448923)
25. 23 not 24 (2089714)
26. 25 and 14 (88)
27. 2009****.ed. (506278)
28. 26 and 27 (7)
29. from 28 keep 1-7 (7)
Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity-maximizing version
(2008 revision); OVID format
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. Animals.sh. not (humans.sh. and animals.sh.)
11. 9 not 10
Total number of records found: 63
24Acupuncture for cancer pain in adults (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. CENTRAL search strategy
1. Cancer near pain
2. Bone Pain
3. Metasta$
4. #1 or #2 or #3
5. Acupuncture
6. Complementary therapy [ti,ab,kw]
7. #5 and #6
8. #4 and #7
Total number of records found: 51
Appendix 3. AMED (Allied and Complementary Medicine) search strategy
1. (acupuncture or acupressure or acupoint* or electroacupuncture or electro-acupuncture or meridian* or moxibust* or
“traditional chinese medicine” or “traditional oriental medicine”).mp. [mp=abstract, heading words, title] (8895)
2. (neoplasm* or cancer* or carcino* or malignan* or tumor* or tumour*).mp. [mp=abstract, heading words, title] (12845)
3. pain*.mp. [mp=abstract, heading words, title] (21140)
4. (analges* or nocicept* or neuropath*).mp. [mp=abstract, heading words, title] (4063)
5. 4 or 3 (22808)
6. 1 and 2 and 5 (71)
7. exp randomized controlled trials/ (1350)
8. exp double blind method/ (388)
9. exp random allocation/ (288)
10. (random$ or control$ or placebo$ or factorial).mp. [mp=abstract, heading words, title] (27645)
11. (double adj blind).mp. [mp=abstract, heading words, title] (1296)
12. (single adj blind).mp. [mp=abstract, heading words, title] (305)
13. exp comparative study/ (4134)
14. or/7-13 (30652)
15. 6 and 14 (27)
16. from 15 keep 1-27 (27)
Total number of records found: 27
Appendix 4. EMBASE search strategy
1. acupuncture/ or acupuncture analgesia/ or electroacupuncture/ or acupressure/ (13166)
2. exp ACUPUNCTURE THERAPY/ (13179)
3. chinese medicine/ or oriental medicine/ (8536)
4. (acupuncture or acupressure or acupoint* or electroacupuncture or electro-acupuncture or meridian* or moxibust* or
“traditional chinese medicine” or “traditional oriental medicine”).mp. [mp=title, abstract, subject headings, heading word, drug trade
name, original title, device manufacturer, drug manufacturer name] (18853)
5. 2 or 4 or 1 or 3 (23706)
6. exp Neoplasms/ (1481026)
7. (neoplasm* or cancer* or carcino* or malignan* or tumor* or tumour*).mp. [mp=title, abstract, subject headings, heading word,
drug trade name, original title, device manufacturer, drug manufacturer name] (1605212)
8. or/6-7 (1845304)
9. exp Pain/ (375235)
10. pain*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer name] (371531)
11. Analgesia/ (43678)
12. (analges* or nocicept* or neuropath*).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title,
device manufacturer, drug manufacturer name] (221904)
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13. or/9-12 (617984)
14. 8 and 13 and 5 (615)
15. random*.ti,ab. (397881)
16. factorial*.ti,ab. (8307)
17. (crossover* or cross over* or cross-over*).ti,ab. (39692)
18. placebo*.ti,ab. (110792)
19. (doubl* adj blind*).ti,ab. (85277)
20. (singl* adj blind*).ti,ab. (7523)
21. assign*.ti,ab. (109581)
22. allocat*.ti,ab. (34657)
23. volunteer*.ti,ab. (99728)
24. CROSSOVER PROCEDURE.sh. (21298)
25. DOUBLE-BLIND PROCEDURE.sh. (72449)
26. RANDOMIZED CONTROLLED TRIAL.sh. (168923)
27. SINGLE BLIND PROCEDURE.sh. (8167)
28. or/15-27 (665787)
29. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/ (3460363)
30. HUMAN/ (6490253)
31. 29 and 30 (541210)
32. 29 not 31 (2919153)
33. 28 not 32 (579835)
34. 33 and 14 (107)
35. from 34 keep 1-107 (107)
Total number of records found: 77
Appendix 5. PsycINFO search strategy
1. (acupuncture or acupressure or acupoint* or electroacupuncture or electro-acupuncture or meridian* or moxibust* or “traditional
chinese medicine” or “traditional oriental medicine”).mp. [mp=title, abstract, heading word, table of contents, key concepts] (1679)
2. (neoplasm* or cancer* or carcino* or malignan* or tumor* or tumour*).mp. [mp=title, abstract, heading word, table of contents,
key concepts] (28978)
3. pain*.mp. [mp=title, abstract, heading word, table of contents, key concepts] (50211)
4. (analges* or nocicept* or neuropath*).mp. [mp=title, abstract, heading word, table of contents, key concepts] (22783)
5. 4 or 3 (63662)
6. 1 and 2 and 5 (21)
7. randomized.ab. (18521)
8. placebo.ab. (21105)
9. randomly.ab. (33558)
10. trial.ab. (36218)
11. groups.ab. (234910)
12. or/7-11 (304624)
13. 6 and 12 (8)
14. from 13 keep 1-8 (8)
Total number of records found: 3
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Appendix 6. SPORTDiscus (via EBSCO) search strategy
1. S1 and S2 and S3 (9)
2. pain* or analges* or nocicept* or neuropath* (30909)
3. neoplasm* or cancer* or carcino* or malignan* or tumor* or tumour* (13267)
4. acupuncture or acupressure or acupoint* or electroacupuncture or electro-acupuncture or meridian* or moxibust* (1062)
Total number of records found: 9
WH A T ’ S N E W
Last assessed as up-to-date: 23 November 2010.
Date Event Description
25 April 2012 Amended A correction was made by moving the ’Summary of included studies’ from the ’Summary of findings’
table section to the ’Additional tables’ section in the review
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D E C L A R A T I O N S O F I N T E R E S T
None known
S O U R C E S O F S U P P O R T
Internal sources
• Leeds Metropolitan University, UK.
Academic support for the project.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We had planned to do a subgroup analysis on cancer-induced bone pain but this was not possible because this condition was not
specifically mentioned in any of the papers reviewed. Heterogeneity prevented pooling of data and meta-analysis and it was only possible
to do a forest plot for one study (Alimi 2003) because of the use of poorly defined categorical data in the remaining two studies.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pain Management; Acupuncture Therapy [∗methods]; Acupuncture, Ear [methods]; Neoplasms [∗complications]; Pain [etiology];
Pain Measurement; Randomized Controlled Trials as Topic
MeSH check words
Adult; Humans
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